Serind Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.68 Cr
as on 09-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -10952.16%
(FY 2020)
- Ebitda -11605.60%
(FY 2020)
- Net Worth -24.41%
(FY 2020)
- Total Assets 38.12%
(FY 2020)
About Serind Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satyanarayana Nandiraju and Sandhya Nandiraju serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC116257
- Company No.
116257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Serind Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Nandiraju  | Director | 30-Mar-2017 | Current |
| Sandhya Nandiraju | Director | 30-Mar-2017 | Current |
Financial Performance of Serind Pharma.
Serind Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10952.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serind Pharma?
In 2019, Serind Pharma had a promoter holding of 50.15% and a public holding of 49.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clinsync Clinical Research Private LimitedActive 13 years 9 monthsSandhya Nandiraju is a mutual person
Vinda Healthcare Private LimitedActive 7 years 10 monthsSatyanarayana Nandiraju and Sandhya Nandiraju are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Serind Pharma?
Unlock and access historical data on people associated with Serind Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serind Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serind Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
